UBS Group’s Lam Research LRCX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$30.5M Sell
142,700
-111,300
-44% -$24.9M ﹤0.01% 2152
2025
Q4
$43.5M Buy
254,000
+112,600
+80% +$17.5M 0.01% 1756
2025
Q3
$18.9M Buy
141,400
+40,400
+40% +$4.28M ﹤0.01% 2627
2025
Q2
$9.83M Sell
101,000
-174,500
-63% -$13.8M ﹤0.01% 3094
2025
Q1
$20M Sell
275,500
-100,090
-27% -$7.88M ﹤0.01% 2326
2024
Q4
$27.1M Buy
375,590
+21,460
+6% +$1.63M 0.01% 2009
2024
Q3
$28.9M Buy
354,130
+42,130
+14% +$3.66M 0.01% 1550
2024
Q2
$33.2M Sell
312,000
-49,330
-14% -$4.73M 0.01% 1312
2024
Q1
$35.1M Buy
361,330
+285,000
+373% +$25.1M 0.01% 1279
2023
Q4
$5.98M Sell
76,330
-73,670
-49% -$5.02M ﹤0.01% 2596
2023
Q3
$9.4M Hold
150,000
﹤0.01% 2034
2023
Q2
$9.64M Sell
150,000
-812,000
-84% -$45.8M ﹤0.01% 1986
2023
Q1
$51M Sell
962,000
-867,000
-47% -$42.5M 0.02% 768
2022
Q4
$76.9M Sell
1,829,000
-58,660
-3% -$2.45M 0.03% 599
2022
Q3
$69.1M Buy
1,887,660
+65,470
+4% +$2.91M 0.03% 556
2022
Q2
$77.7M Buy
1,822,190
+888,190
+95% +$42.3M 0.03% 531
2022
Q1
$50.2M Buy
934,000
+150,000
+19% +$8.73M 0.02% 843
2021
Q4
$56.4M Buy
784,000
+603,000
+333% +$37.8M 0.02% 888
2021
Q3
$10.3M Buy
181,000
+174,000
+2,486% +$10.6M ﹤0.01% 1996
2021
Q2
$455K Buy
+7,000
New +$442K ﹤0.01% 4802
2020
Q2
Sell
-129,000
Closed -$3.1M 8175
2020
Q1
$3.1M Sell
129,000
-276,000
-68% -$7.95M ﹤0.01% 2353
2019
Q4
$11.8M Buy
405,000
+323,000
+394% +$8.58M ﹤0.01% 1803
2019
Q3
$1.9M Buy
+82,000
New +$1.72M ﹤0.01% 3339
2019
Q2
Sell
-35,890
Closed -$642K 8027
2019
Q1
$642K Sell
35,890
-315,510
-90% -$5.26M ﹤0.01% 3890
2018
Q4
$4.79M Buy
+351,400
New +$5.04M ﹤0.01% 2188
2018
Q3
Sell
-27,000
Closed -$467K 8134
2018
Q2
$467K Sell
27,000
-973,000
-97% -$18.7M ﹤0.01% 4360
2018
Q1
$20.3M Buy
1,000,000
+578,000
+137% +$11.4M 0.01% 1153
2017
Q4
$7.77M Buy
422,000
+409,000
+3,146% +$8.04M ﹤0.01% 1937
2017
Q3
$241K Sell
13,000
-11,000
-46% -$178K ﹤0.01% 4718
2017
Q2
$339K Buy
+24,000
New +$352K ﹤0.01% 4401
2017
Q1
Sell
-580,000
Closed -$6.13M 7824
2016
Q4
$6.13M Hold
580,000
﹤0.01% 1911
2016
Q3
$5.49M Sell
580,000
-90,000
-13% -$819K ﹤0.01% 1934
2016
Q2
$5.63M Buy
+670,000
New +$5.38M ﹤0.01% 1842
2016
Q1
Sell
-3,000
Closed -$24K 7933
2015
Q4
$24K Sell
3,000
-45,000
-94% -$338K ﹤0.01% 6555
2015
Q3
$314K Sell
48,000
-500,000
-91% -$3.66M ﹤0.01% 4276
2015
Q2
$4.46M Buy
548,000
+435,000
+385% +$3.42M ﹤0.01% 2196
2015
Q1
$794K Buy
113,000
+34,000
+43% +$269K ﹤0.01% 3771
2014
Q4
$627K Buy
+79,000
New +$612K ﹤0.01% 3985

Other funds holding LRCX

UBS Group's LRCX Position: Q1 2026 in Review

UBS Group reduced its Lam Research (LRCX) stake by 16% in Q1 2026, selling an estimated $281M and leaving 6,526,433 shares worth $1.39B. The position accounts for 0.21% of the portfolio, ranked #79.

UBS Group first reported a position in LRCX in Q4 2014 and has held it in 46 quarters since. 2,630 funds tracked by Wall St. Rank hold LRCX as of Q1 2026.

  • UBS Group held 6,526,433 shares of Lam Research worth $1.39B as of Q1 2026.
  • UBS Group sold 1,254,621 Lam Research shares in Q1 2026, an estimated $281M.
  • Lam Research made up 0.21% of UBS Group's portfolio in Q1 2026, its #79 holding.
  • UBS Group first reported a position in Lam Research in Q4 2014 and has held it in 46 quarters since.
  • 2,630 funds tracked by Wall St. Rank held Lam Research as of Q1 2026.

Based on UBS Group's 13F filing for Q1 2026, filed 5 May 2026.